Concepedia

First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer

Vincent Chung, Elisabeth I. Heath, William R. Schelman, Brendan M. Johnson, Lyndon C. Kirby, Kerlin M. Lynch, Jeffrey Botbyl, Thomas A. Lampkin, Kyle D. Holen

Cancer Chemotherapy and Pharmacology · 2011 · 81 citations · 7 references

DOI

Concepts

References

7

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +17

Accelerated Titration Designs for Phase I Clinical Trials in Oncology

Richard Simon, Larry Rubinstein, Susan G. Arbuck et al. · JNCI Journal of the National Cancer Institute · 1997 · 632 citations · Full text

Antitumor activity of an allosteric inhibitor of centromere-associated protein-E

Kenneth W. Wood, Latesh Lad, Lusong Luo et al. · Proceedings of the National Academy of Sciences · 2010 · 252 citations · Full text

, , +18

Phase II Study of the Cyclin-Dependent Kinase Inhibitor Flavopiridol Administered to Patients With Advanced Gastric Carcinoma

Gary K. Schwartz, David H. Ilson, Leonard B. Saltz et al. · Journal of Clinical Oncology · 2001 · 198 citations

Anemia in Oncology Practice

Faruk Taş, Yeşim Eralp, Mert Başaran et al. · American Journal of Clinical Oncology · 2002 · 120 citations

, , +17